New risk seen in hormone therapy
Hormone therapy doubled the risk of Alzheimer's disease and other types of dementia in a large study of women who began in treatment at age 65 or older, researchers reported Wednesday. The finding
International Herald Tribune (Bangkok)
-
-
Another earthquake, 3d in week, hits Algeria
A strong new earthquake shook the Algiers region Wednesday. The aftershock appeared to be of similar strength to one that struck the area Tuesday, sending people rushing out of buildings to the
-
Nations set to give WHO threat-response powers
The World Health Organization's 192 member nations were preparing Wednesday to grant it sweeping new powers to respond to international health threats like SARS and bioterrorist attacks. Under the
-
Climate change at Exxon
Exxon Mobil Corp. has publicly softened its stance toward global warming over the past year, with a pledge of $10 million in annual donations for 10 years to Standford University for climate
-
Battle lines are drawn in genetic crop dispute
President George W. Bush has called European opposition to genetically altered crops a threat to efforts to end world hunger. But even many critics of Europe's stance say the president's argument
-
Cheating the environment
President George W. Bush's budgets have generally shortchanged environmental programs. His proposed budget for all discretionary (non farm) environmental protection programs for fiscal 2004 is down
-
Bayer's bad medicine
In the first years of the AIDS epidemic,many victims of the disease were hemophiliacs who used a clotting medicine made by mixing blood plasma from many donors. After the medicine's makers discovered
-
Kenya exports fancy foods but can't feed itself
In the last ten years, the lake shores, that spreads across Africa's famed Rift Valley, have exchanged any lingering memories of the past for a booming industry in the cultivation and sale of
-
Biotech is benign
Plenty of pundits have had a got at America's decision to join several other major food-producing nations in asking the European Union to end its moratorium on approving agricultural biotechnology
-
Faster drug reviews urged to fight obesity
Mark McClellan, commissioner of the U.S. Food and Drug Administration, said he wants to apply a fast-track review process, normally reserved for drugs for terminal cancer and AIDS patients, to drugs